BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29086446)

  • 1. In vivo analysis at the cellular level reveals similar steatosis induction in both hepatitis C virus genotype 1 and 3 infections.
    Campana B; Calabrese D; Matter MS; Terracciano LM; Wieland SF; Heim MH
    J Viral Hepat; 2018 Mar; 25(3):262-271. PubMed ID: 29086446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
    Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
    Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
    Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani ES; Pawlotsky JM; Dhumeaux D
    Gut; 2004 Mar; 53(3):420-4. PubMed ID: 14960527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
    Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
    J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.
    Jhaveri R; McHutchison J; Patel K; Qiang G; Diehl AM
    J Infect Dis; 2008 Jan; 197(2):283-91. PubMed ID: 18177246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
    Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
    Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.
    Ferguson D; Zhang J; Davis MA; Helsley RN; Vedin LL; Lee RG; Crooke RM; Graham MJ; Allende DS; Parini P; Brown JM
    J Lipid Res; 2017 Feb; 58(2):420-432. PubMed ID: 27941027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.
    Depla M; d'Alteroche L; Le Gouge A; Moreau A; Hourioux C; Meunier JC; Gaillard J; de Muret A; Bacq Y; Kazemi F; Avargues A; Roch E; Piver E; Gaudy-Graffin C; Giraudeau B; Roingeard P
    PLoS One; 2012; 7(3):e33749. PubMed ID: 22479436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model.
    Hourioux C; Patient R; Morin A; Blanchard E; Moreau A; Trassard S; Giraudeau B; Roingeard P
    Gut; 2007 Sep; 56(9):1302-8. PubMed ID: 17213339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and liver steatosis.
    Ramalho F
    Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.
    Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ
    J Viral Hepat; 2011 Apr; 18(4):e144-52. PubMed ID: 21070504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
    Rubbia-Brandt L; Quadri R; Abid K; Giostra E; Malé PJ; Mentha G; Spahr L; Zarski JP; Borisch B; Hadengue A; Negro F
    J Hepatol; 2000 Jul; 33(1):106-15. PubMed ID: 10905593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C.
    Schelbert S; Schindeldecker M; Drebber U; Witzel HR; Weinmann A; Dries V; Schirmacher P; Roth W; Straub BK
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.
    Galli A; Ramirez S; Bukh J
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
    Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
    Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
    Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
    Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus diversity and hepatic steatosis.
    Roingeard P
    J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism.
    Koletzko L; Mahli A; Hellerbrand C
    Pathol Res Pract; 2018 Oct; 214(10):1700-1706. PubMed ID: 30201523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.